539872 — Bajaj Healthcare Share Price
0.000.00%
Last trade - 00:00- IN₹8.68bn
- IN₹12.14bn
- IN₹6.73bn
- 48
- 21
- 19
- 15
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.75 | ||
| Price to Tang. Book | 2.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.74 | ||
| EV to EBITDA | 15.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.67% | ||
| Return on Equity | 6.32% | ||
| Operating Margin | 10.35% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,701.74 | 4,100.08 | 6,569.84 | 6,798.9 | 6,732.92 | n/a | n/a | 15.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +8.09 | +53.75 | +229.27 | -14.11 | -40.6 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. Its segments include Bulk Drugs and Formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. Its APIs include ascorbic acid, CH Base and its derivatives, citicoline sodium, carbamazepine, theobromine, ferrous ascorbate, doxofylline, oxcarbazepine, choline bitartrate and its derivatives, octenidine dihydrochloride, vildagliptin, ticagrelor, diosmin, hesperidin and others. Its FDFs include Cellin 500, Septran DS Tablet, Vitajaj C tables 500mg, Ticajaj 90 tablets, Ecojaj 75mg & 150mg, Deferajaj 400mg & 500mg, Vildajaj 50mg and Vildajaj M 50/500. It also offers Inositol Nicotinate and Magnesium L-Threonate.
Directors
- Sajankumar Bajaj CHM (56)
- Rupesh Nikam CFO (32)
- Nandkumar Soni SVP
- Aakashkumar Kesari CCO
- Anil Jain MDR (41)
- Namrata Bajaj EDR (30)
- Dhananjay Hatle EDR (44)
- Kuldeep Joshi OTH
- Kanu Patel OTH
- R. Patil OTH
- Ram Banarase NID (58)
- Hemant Karnik NID (57)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 15th, 1993
- Public Since
- May 10th, 2016
- No. of Shareholders
- 26,440
- No. of Employees
- 1,063
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 27,598,400
- Address
- 202-204, THANE, 400604
- Web
- http://www.bajajhealth.com/
- Phone
- +91 2240177400
- Auditors
- Chaturvedi & Agrawal
Upcoming Events for 539872
Q1 2025 Bajaj Healthcare Ltd Earnings Release
Bajaj Healthcare Ltd Annual Shareholders Meeting
Similar to 539872
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Bajaj Healthcare share price?
As of Today at 19:03 UTC, shares in Bajaj Healthcare are trading at IN₹314.70. This share price information is delayed by 15 minutes.
How has the Bajaj Healthcare share price performed this year?
Shares in Bajaj Healthcare last closed at IN₹314.70 and the price had moved by -1.89% over the past 365 days. In terms of relative price strength the Bajaj Healthcare share price has underperformed the S&P BSE 100 Index by -23.9% over the past year.
What are the analyst and broker recommendations for Bajaj Healthcare?
There is no consensus recommendation for this security.
What is the Bajaj Healthcare dividend yield?
The Bajaj Healthcare dividend yield is 0.32% based on the trailing twelve month period.
Does Bajaj Healthcare pay a dividend?
Last year, Bajaj Healthcare paid a total dividend of IN₹1.00, and it currently has a trailing dividend yield of 0.32%. We do not have any data on when Bajaj Healthcare is to next pay dividends.
When does Bajaj Healthcare next pay dividends?
We do not have data on when Bajaj Healthcare is to next pay dividends. The historic dividend yield on Bajaj Healthcare shares is currently 0.32%.
How do I buy Bajaj Healthcare shares?
To buy shares in Bajaj Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bajaj Healthcare?
As of the previous close price of IN₹314.70, shares in Bajaj Healthcare had a market capitalisation of IN₹8.68bn.
Where are Bajaj Healthcare shares listed?
Here are the trading details for Bajaj Healthcare:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539872
What kind of share is Bajaj Healthcare?
Based on an overall assessment of its quality, value and momentum Bajaj Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bajaj Healthcare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Bajaj Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bajaj Healthcare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -38.72%.
As of the last closing price of IN₹314.70, shares in Bajaj Healthcare were trading -13.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bajaj Healthcare PE Ratio?
The Bajaj Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹314.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bajaj Healthcare?
Bajaj Healthcare's management team is headed by:
- Sajankumar Bajaj - CHM
- Rupesh Nikam - CFO
- Nandkumar Soni - SVP
- Aakashkumar Kesari - CCO
- Anil Jain - MDR
- Namrata Bajaj - EDR
- Dhananjay Hatle - EDR
- Kuldeep Joshi - OTH
- Kanu Patel - OTH
- R. Patil - OTH
- Ram Banarase - NID
- Hemant Karnik - NID